BGI Genomics Co., Ltd. (SHE:300676)

BGI Genomics Statistics

Total Valuation

BGI Genomics has a market cap or net worth of CNY 17.62 billion. The enterprise value is 14.72 billion.

Market Cap	17.62B
Enterprise Value	14.72B

Important Dates

The next estimated earnings date is Thursday, April 30, 2026.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	n/a

Share Statistics

BGI Genomics has 383.85 million shares outstanding. The number of shares has increased by 2.32% in one year.

Current Share Class	383.85M
Shares Outstanding	383.85M
Shares Change (YoY)	+2.32%
Shares Change (QoQ)	-0.53%
Owned by Insiders (%)	1.10%
Owned by Institutions (%)	10.67%
Float	217.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	701.10
PS Ratio	4.74
PB Ratio	1.88
P/TBV Ratio	1.99
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-18.40
EV / Sales	3.96
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-23.04

Financial Position

The company has a current ratio of 2.81, with a Debt / Equity ratio of 0.07.

Current Ratio	2.81
Quick Ratio	2.49
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	-1.04
Interest Coverage	-28.41

Financial Efficiency

Return on equity (ROE) is -8.42% and return on invested capital (ROIC) is -4.48%.

Return on Equity (ROE)	-8.42%
Return on Assets (ROA)	-3.57%
Return on Invested Capital (ROIC)	-4.48%
Return on Capital Employed (ROCE)	-7.33%
Revenue Per Employee	1.00M
Profits Per Employee	-216,076
Employee Count	3,702
Asset Turnover	0.29
Inventory Turnover	3.79

Taxes

In the past 12 months, BGI Genomics has paid 9.04 million in taxes.

Income Tax	9.04M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.55% in the last 52 weeks. The beta is 0.79, so BGI Genomics's price volatility has been lower than the market average.

Beta (5Y)	0.79
52-Week Price Change	-2.55%
50-Day Moving Average	49.27
200-Day Moving Average	51.84
Relative Strength Index (RSI)	33.23
Average Volume (20 Days)	4,682,478

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BGI Genomics had revenue of CNY 3.71 billion and -799.91 million in losses. Loss per share was -1.93.

Revenue	3.71B
Gross Profit	1.37B
Operating Income	-730.70M
Pretax Income	-805.11M
Net Income	-799.91M
EBITDA	-280.81M
EBIT	-730.70M
Loss Per Share	-1.93

Balance Sheet

The company has 3.70 billion in cash and 665.55 million in debt, giving a net cash position of 3.03 billion or 7.89 per share.

Cash & Cash Equivalents	3.70B
Total Debt	665.55M
Net Cash	3.03B
Net Cash Per Share	7.89
Equity (Book Value)	9.37B
Book Value Per Share	22.17
Working Capital	4.20B

Cash Flow

In the last 12 months, operating cash flow was -198.14 million and capital expenditures -440.71 million, giving a free cash flow of -638.84 million.

Operating Cash Flow	-198.14M
Capital Expenditures	-440.71M
Free Cash Flow	-638.84M
FCF Per Share	-1.66

Margins

Gross margin is 36.99%, with operating and profit margins of -19.67% and -21.53%.

Gross Margin	36.99%
Operating Margin	-19.67%
Pretax Margin	-21.67%
Profit Margin	-21.53%
EBITDA Margin	-7.56%
EBIT Margin	-19.67%
FCF Margin	n/a

Dividends & Yields

BGI Genomics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.32%
Shareholder Yield	-2.32%
Earnings Yield	-4.54%
FCF Yield	-3.63%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BGI Genomics has an Altman Z-Score of 4.88 and a Piotroski F-Score of 2.

Altman Z-Score	4.88
Piotroski F-Score	2